Comparing ED Medications: Levitra and Others

Figure 2: Placebo-subtracted point estimates (with 90% CI)

• The development of vardenafil was a significant advancement in ED treatment.
• It offered an alternative for patients who did not respond to or tolerate sildenafil.
• Its development involved extensive clinical research and safety testing.
• Ongoing pharmacovigilance continues to monitor its safety profile worldwide.
• Research into new formulations and applications for PDE5 inhibitors continues.
• The goal is always to improve patient outcomes, safety, and quality of life.

of mean maximal blood pressure and heart rate effects

¿Qué otros fármacos afectarán a vardenafil?

Vardenafil is metabolized predominantly by the hepatic levitra no prescription online enzyme CYP3A4, with contribution from the CYP3A5 and CYP2C isoforms. The major circulating metabolite, M1, results from desethylation at the piperazine moiety of vardenafil. The plasma concentration of M1 is approximately 26% that of the parent compound. This metabolite shows a phosphodiesterase selectivity profile similar to that of vardenafil and an in vitro inhibitory potency for PDE5 28% of that of vardenafil. Therefore, M1 accounts for approximately 7% of total pharmacologic activity.

Drug Interactions

The total body clearance of vardenafil is 56 L/h, and the terminal half-life of vardenafil and its primary metabolite (M1) is approximately 4-5 hours. After oral administration, vardenafil is excreted as metabolites predominantly in the feces (approximately 91-95% of administered oral dose) and to a lesser extent in the urine (approximately 2-6% of administered oral dose). Pediatrics: Vardenafil trials were not conducted in the pediatric population. Geriatrics: In a healthy volunteer study of elderly males (≥65 years) and younger males (18–45 years), mean Cmax and AUC were 34% and 52% higher, respectively, in the elderly males (see PRECAUTIONS, Geriatric Use and DOSAGE AND ADMINISTRATION). Consequently, a lower starting dose of LEVITRA (5 mg) in patients ≥65 years of age should be considered. of pre-dosing with LEVITRA 20 mg at 24, 8,

4, and 1 hour before 0.4 mg NTG sublingually.

More about Levitra (vardenafil)

No, Levitra is not inherently bad for the kidneys when used as prescribed. Individuals with severe kidney disease require dose adjustments due to slower medication clearance, increasing side effect risks. It remains safe for most with mild impairment under medical supervision. Efficacy of patients with LEVITRA treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: LEVITRA treatment improved the patient's erectiondate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: LEVITRA improved the patient's erection after Minimum and Maximum Intervals between LEVITRA intake and the start of intercoursedate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Reporting a second successful intercourse within 24 hours of dosingdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Patients prefer LEVITRA over last Erectile Dysfunction treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Tolerability of patients with LEVITRA treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionYesSafety Issue: Generic name: vardenafil Other brand names of vardenafil include: Levitra Drug class: Impotence medications The Levitra brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.

Patient resources

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. LEVITRA- vardenafil hydrochloride tablet, film coated APHENA PHARMA SOLUTIONS - TENNESSEE, INC. LEVITRA® is an oral therapy for the treatment of erectile dysfunction. Vardenafil HCl is designated chemically as piperazine, 1-[[3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f ][1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl]-4-ethyl-, monohydrochloride and has the following structural formula: Vardenafil HCl is a nearly colorless, solid substance with a molecular weight of 579.1 g/mol and a solubility of 0.11 mg/mL in water. LEVITRA is formulated as orange, round, film-coated tablets with “BAYER” cross debossed on one side and “2.5”, “5”, “10”, and “20” on the other side corresponding to 2.5 mg, 5 mg, 10 mg, and 20 mg of vardenafil, respectively. Because the disease state of patients requiring nitrate

• Psychological factors can contribute to or cause erectile dysfunction.
• Levitra can be effective for ED with a psychogenic component.
• It may help break the cycle of anxiety and performance-related stress.
• Successful treatment with medication can improve self-confidence.
• It is often used in conjunction with psychological counseling or sex therapy.
• A holistic approach to ED treatment addresses both physical and mental aspects.

therapy is anticipated to increase the likelihood of hypotension,

¿Cuáles son los posibles efectos secundarios de vardenafil?

Vardenafil is eliminated predominantly by hepatic metabolism, mainly by CYP3A4 and to a minor extent, CYP2C isoforms. Concomitant use with potent CYP3A4 inhibitors such as ritonavir, indinavir, ketoconazole, as well as moderate CYP3A inhibitors such as erythromycin results in significant increases of plasma levels of vardenafil (see PRECAUTIONS, WARNINGS and DOSAGE AND ADMINISTRATION). Mean vardenafil plasma concentrations measured after the administration of a single oral dose of 20 mg to healthy male volunteers are depicted in Figure 1. Figure 1: Plasma Vardenafil Concentration (Mean ± SD) Curve for a Single 20 mg LEVITRA Dose Vardenafil is rapidly absorbed with absolute bioavailability of approximately 15%. Maximum observed plasma concentrations after a single 20 mg dose in healthy volunteers are usually reached between 30 minutes and 2 hours (median 60 minutes) after oral dosing in the fasted state.

How to use Levitra 20mg?

Two food-effect studies were conducted which showed that high-fat meals caused a reduction in Cmax by 18%-50%. The mean steady-state volume of distribution (Vss) for vardenafil is 208 L, indicating extensive tissue distribution. Vardenafil and its major circulating metabolite, M1, are highly bound to plasma proteins (about 95% for parent drug and M1). This protein binding is reversible and independent of total drug concentrations. Following a single oral dose of 20 mg vardenafil in healthy volunteers, a mean of 0.00018% of the administered dose was obtained in semen 1.5 hours after dosing. the use of vardenafil by patients on nitrate therapy

Strength and Substitute

Renal Insufficiency: In volunteers with mild renal impairment (CLcr = 50-80 ml/min), the pharmacokinetics of vardenafil were similar to those observed in a control group with normal renal function. In the moderate (CLcr = 30-50 ml/min) or severe (CLcr<30 ml/min) renal impairment groups, the AUC of vardenafil was 20–30% higher compared to that observed in a control group with normal renal function (CLcr>80 ml/min). Vardenafil pharmacokinetics have not been evaluated in patients requiring renal dialysis (see buy levitra online canadian pharmacy PRECAUTIONS, Renal Insufficiency, and DOSAGE AND ADMINISTRATION). Hepatic Insufficiency: In volunteers with mild hepatic impairment (Child-Pugh A), the Cmax and AUC following a 10 mg vardenafil dose were increased by 22% and 17%, respectively, compared to healthy control subjects. In volunteers with moderate hepatic impairment (Child-Pugh B), the Cmax and AUC following a 10 mg vardenafil dose were increased by 130% and 160%, respectively, compared to healthy control subjects. or on nitric oxide donors is contraindicated (see CONTRAINDICATIONS).

¿Qué es vardenafil?

Penile erection is a hemodynamic process initiated by the relaxation of smooth muscle in the corpus cavernosum and its associated arterioles. During sexual stimulation, nitric oxide is released from nerve endings price levitra 10mg and endothelial cells in the corpus cavernosum. Nitric oxide activates the enzyme guanylate cyclase resulting in increased synthesis of cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the corpus cavernosum. The cGMP in turn triggers smooth muscle relaxation, allowing increased blood flow into the penis, resulting in erection. The tissue concentration of cGMP is regulated by both the rates of synthesis and degradation via phosphodiesterases (PDEs).

Are you currently using Vardenafil (Levitra, Staxyn)?

The most abundant PDE in the human corpus cavernosum is the cGMP-specific phosphodiesterase type 5 (PDE5); therefore, the inhibition of PDE5 enhances erectile function by increasing the amount of cGMP. Because sexual stimulation is required to initiate the local release of nitric oxide, the inhibition of PDE5 has no effect in the absence of sexual stimulation. In vitro studies have shown that vardenafil is a selective inhibitor of PDE5. The inhibitory effect of vardenafil is more selective on PDE5 than for other known phosphodiesterases (>15-fold relative to PDE6, >130-fold relative to PDE1, >300-fold relative to PDE11, and >1,000-fold relative to PDE2, 3, 4, 7, 8, 9, and 10). The pharmacokinetics of vardenafil are approximately dose proportional over the recommended dose range. The effect of 10 mg and 80 mg vardenafil on

QT interval was evaluated in a single-dose, double-blind, randomized, placebo-

and active-controlled (moxifloxacin 400 mg) crossover study in 59 healthy

• Traveling with prescription medication is generally permitted.
• Keep medication in its original pharmacy packaging with the prescription label.
• This is especially important for international travel to avoid customs issues.
• Check the regulations of your destination country regarding prescription drugs.
• Do not pack medication in checked luggage; keep it in your carry-on bag.
• Ensure you have an adequate supply for the duration of your trip.

males (81% White, 12% Black, 7% Hispanic) aged 45-60 years.

• Levitra 20mg is contraindicated in men using nitrate medications.
• The medication can interact with certain antibiotics and antifungals.
• Some users report mild side effects that resolve without medical help.
• If an erection lasts more than 4 hours, seek emergency medical attention.
• Use proper storage to maintain medication potency and safety.

The QT interval was measured at one hour post dose because

¿Cuál es la información más importante que debo saber sobre vardenafil?

Vardenafil may add to the blood pressure lowering effects of antihypertensive agents (see PRECAUTIONS, Drug Interactions). A study was conducted in which the blood pressure and heart rate response to 0.4 mg nitroglycerin (NTG) sublingually was evaluated in 18 healthy subjects following pretreatment with LEVITRA 20 mg at various times before NTG administration. LEVITRA 20 mg caused an additional time-related reduction in blood pressure and increase in heart rate in association with NTG administration. The blood pressure effects were observed when LEVITRA 20 mg was dosed 1 or 4 hours before NTG and the heart rate effects were observed when 20 mg was dosed 1, 4, or 8 hours before NTG. Additional blood pressure and heart rate changes were not detected when LEVITRA 20 mg was dosed 24 hours before NTG. this time point approximates the average time of peak vardenafil concentration.

Further information

Consequently, a starting dose of 5 mg is recommended for patients with moderate hepatic impairment, and the maximum dose should not exceed 10 mg (see PRECAUTIONS and DOSAGE AND ADMINISTRATION). Vardenafil has not been evaluated in patients with severe (Child-Pugh C) hepatic impairment. In a clinical pharmacology study of patients with erectile dysfunction, single doses of vardenafil 20 mg caused a mean maximum decrease in supine blood pressure of 7 mmHg systolic and 8 mmHg diastolic (compared to placebo), accompanied by a mean maximum increase of heart rate of 4 beats per minute. The maximum decrease in blood pressure occurred between 1 and 4 hours after dosing. Following multiple dosing for 31 days, similar blood pressure responses were observed on Day 31 as on Day 1.